As medical cannabis continues to grow, cannabinoids other than THC have started to be researched and used more frequently. Cannabigerol or CBG, is one of those newly researched cannabinoids that has become a hot topic. Given the title “mother of all cannabinoids,” it develops into all the other cannabinoids as the plant matures.
Cannabigerol has piqued the interest of many because it has no psychoactive effects and research has shown that it can help with a multitude of ailments. CBG interacts with the immune system to become an anti-inflammatory. Inflammation is your immune system’s natural signal to heal. However, when the system is dysregulated and continues with the response, it can hurt other systems within the body. Inflammation can show up as a symptom of conditions such as chronic pain, arthritis, IBD, MS, Chron’s disease, and others.
CBG may also help people with cancer. It has shown to exhibit cytotoxic effects on various cancers that inhibit growth and stop it from dividing. It has also been known to sensitize cancer cells, making chemotherapy more effective. An extra bonus is that CBG alleviates nausea and vomiting, as well as increases appetite, which are common side effects of chemotherapy.
As research on CBG continues, more potential benefits are discovered. The cannabinoid has shown signs of anxiety relief, improving sleep quality, neuroprotective benefits, and even hypertension management. This means that CBG may potentially help with mental health conditions as well as neurodegenerative and cardiovascular diseases.
New research on CBG holds a significant promise for therapeutic applications, as evidence already suggests it has a broad-spectrum of benefits. As our understanding of cannabigerol deepens, its role in the medical cannabis world will become more prevalent.
Commentaires